Endogenous testosterone does not improve prediction of incident cardiovascular disease in a community-based cohort of adult men: results from the Tehran Lipid and Glucose Study

References

• McAloon CJ, Boylan LM, Hamborg T, et al. The changing face of cardiovascular disease 2000–2012: an analysis of the world health organisation global health estimates data. Int J Cardiol. 2016;224:256–264.
   PubMed Web of Science ®Google Scholar
• Kim C, Cushman M, Kleindorfer D, et al. A review of the relationships between endogenous sex steroids and incident ischemic stroke and coronary heart disease events. Curr Cardiol Rev. 2015;11:252–260.
   PubMed Web of Science ®Google Scholar
• Su JJ, Park SK, Hsieh TM. The effect of testosterone on cardiovascular disease: a critical review of the literature. Am J Mens Health. 2014;8:470–491.
   PubMed Web of Science ®Google Scholar
• Tudiver F, Talbot Y. Why don't men seek help? Family physicians' perspectives on help-seeking behavior in men. J Fam Pract. 1999;48:47–52.
   PubMed Web of Science ®Google Scholar
• Oskui PM, French WJ, Herring MJ, et al. Testosterone and the cardiovascular system: a comprehensive review of the clinical literature. J Am Heart Assoc. 2013;2:e000272.
   PubMed Web of Science ®Google Scholar
• Decaroli MC, Rochira V. Aging and sex hormones in males. Virulence. 2017;8:545–570.
   PubMed Web of Science ®Google Scholar
• Kloner RA, Carson C, Dobs A, et al. Testosterone and cardiovascular disease. J Am Coll Cardiol. 2016;67:545–557.
   PubMed Web of Science ®Google Scholar
• Haring R, Baumeister SE, Völzke H, et al. Prospective association of low total testosterone concentrations with an adverse lipid profile and increased incident dyslipidemia. Eur J Cardiovasc Prev Rehabil. 2011;18:86–96.
   PubMedGoogle Scholar
• Ding EL, Song Y, Malik VS, et al. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2006;295:1288–1299.
   PubMed Web of Science ®Google Scholar
• Rodriguez A, Muller DC, Metter EJ, et al. Aging, androgens, and the metabolic syndrome in a longitudinal study of aging. J Clin Endocrinol Metab. 2007;92:3568–3572.
   PubMed Web of Science ®Google Scholar
• Ohlsson C, Barrett-Connor E, Bhasin S, et al. High serum testosterone is associated with reduced risk of cardiovascular events in elderly men: the MrOS (Osteoporotic Fractures in Men) study in Sweden. J Am Coll Cardiol. 2011;58:1674–1681.
   PubMed Web of Science ®Google Scholar
• Alkamel A, Boroumand M, Nozari Y. The association between premature coronary artery disease and level of testosterone in young adult males. Arch Iran Med. 2014;17:545.
   PubMed Web of Science ®Google Scholar
• Li L, Guo C-Y, Jia E-Z, et al. Testosterone is negatively associated with the severity of coronary atherosclerosis in men. Asian J Androl. 2012;14:875.
   PubMed Web of Science ®Google Scholar
• Araujo AB, Dixon JM, Suarez EA, et al. Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011;96:3007–3019.
   PubMed Web of Science ®Google Scholar
• Ruige JB, Mahmoud AM, De Bacquer D, et al. Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis. Heart. 2011;97:870–875.
   PubMed Web of Science ®Google Scholar
• Herring MJ, Oskui PM, Hale SL, et al. Testosterone and the cardiovascular system: a comprehensive review of the basic science literature. J Am Heart Assoc. 2013;2:e000271.
   PubMed Web of Science ®Google Scholar
• Shores MM, Matsumoto AM. Testosterone, aging and survival: biomarker or deficiency. Curr Opin Endocrinol Diabetes Obes. 2014;21:209–216.
   PubMed Web of Science ®Google Scholar
• D’Agostino RB, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care the Framingham Heart Study. Circulation. 2008;117:743–753.
   PubMed Web of Science ®Google Scholar
• Bozorgmanesh M, Hadaegh F, Azizi F. Predictive accuracy of the ‘Framingham’s general CVD algorithm’ in a Middle Eastern population: Tehran Lipid and Glucose Study. Int J Clin Pract. 2011;65:264–273.
   PubMed Web of Science ®Google Scholar
• Lee WC, Kim MT, Ko KT, et al. Relationship between serum testosterone and cardiovascular disease risk determined using the Framingham risk score in male patients with sexual dysfunction. World J Mens Health. 2014;32:139–144.
   PubMedGoogle Scholar
• Chock B, Lin T-C, Li C-S, et al. Plasma testosterone is associated with Framingham risk score. Aging Male. 2012;15:134–139.
   PubMed Web of Science ®Google Scholar
• Azizi F, Ghanbarian A, Momenan A, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009;10:5.
   PubMed Web of Science ®Google Scholar
• Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Statist Med. 2004;23:2109–2123.
   PubMed Web of Science ®Google Scholar
• Grønnesby JK, Borgan Ø. A method for checking regression models in survival analysis based on the risk score. Lifetime Data Anal. 1996;2:315–328.
   PubMedGoogle Scholar
• Corona G, Rastrelli G, Monami M, et al. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. Eur J Endocrinol. 2011;165:687–701.
   PubMed Web of Science ®Google Scholar
• Shores MM, Biggs ML, Arnold AM, et al. Testosterone, dihydrotestosterone, and incident cardiovascular disease and mortality in the cardiovascular health study. J Clin Endocrinol Metab. 2014;99:2061–2068.
   PubMed Web of Science ®Google Scholar
• Ärnlöv J, Pencina MJ, Amin S, et al. Endogenous sex hormones and cardiovascular disease incidence in men. Ann Intern Med. 2006;145:176–184.
   PubMed Web of Science ®Google Scholar
• Haring R, Teng Z, Xanthakis V, et al. Association of sex steroids, gonadotropins, and their trajectories with clinical cardiovascular disease and all-cause mortality in elderly men from the Framingham Heart Study. Clin Endocrinol. 2013;78:629–634.
   PubMed Web of Science ®Google Scholar
• Kim C, Halter JB. Endogenous sex hormones, metabolic syndrome, and diabetes in men and women. Curr Cardiol Rep. 2014;16:467.
   PubMed Web of Science ®Google Scholar
• Torkler S, Wallaschofski H, Baumeister SE, et al. Inverse association between total testosterone concentrations, incident hypertension and blood pressure. Aging Male. 2011;14:176–182.
   PubMed Web of Science ®Google Scholar
• Yarnell J, Beswick A, Sweetnam P, et al. Endogenous sex hormones and ischemic heart disease in men. The Caerphilly prospective study. Arterioscler Thromb Vasc Biol. 1993;13:517–520.
   PubMedGoogle Scholar
• Farias JM, Tinetti M, Khoury M, et al. Low testosterone concentration and atherosclerotic disease markers in male patients with type 2 diabetes. J Clin Endocrinol Metab. 2014;99:4698–4703.
   PubMed Web of Science ®Google Scholar
• Segal MR, Bloch DA. A comparison of estimated proportional hazards models and regression trees. Statist Med. 1989;8:539–550.
   PubMed Web of Science ®Google Scholar
• Muller M, Schouw YTvd, Thijssen JHH, et al. Endogenous sex hormones and cardiovascular disease in men. J Clin Endocrinol Metab. 2003;88:5076–5086.
   PubMed Web of Science ®Google Scholar
• Shackleton C. Clinical steroid mass spectrometry: a 45-year history culminating in HPLC–MS/MS becoming an essential tool for patient diagnosis. J Steroid Biochem Mol Biol. 2010;121:481–490.
   PubMed Web of Science ®Google Scholar